ATC code C02

C02AA Rauvolfia alkaloids

 * C02AA01 Rescinnamine
 * C02AA02 Reserpine
 * C02AA03 Combinations of rauwolfia alkaloids
 * C02AA04 Rauwolfia alkaloids, whole root
 * C02AA05 Deserpidine
 * C02AA06 Methoserpidine
 * C02AA07 Bietaserpine
 * C02AA52 Reserpine, combinations
 * C02AA53 Combinations of rauwolfia alkoloids, combinations
 * C02AA57 Bietaserpine, combinations

C02AB Methyldopa

 * C02AB01 Methyldopa (levorotatory)
 * C02AB02 Methyldopa (racemic)

C02AC Imidazoline receptor agonists

 * C02AC01 Clonidine
 * C02AC02 Guanfacine
 * C02AC04 Tolonidine
 * C02AC05 Moxonidine
 * C02AC06 Rilmenidine

C02BA Sulfonium derivatives

 * C02BA01 Trimetaphan

C02BB Secondary and tertiary amines

 * C02BB01 Mecamylamine

C02CA Alpha-adrenoreceptor antagonists

 * C02CA01 Prazosin
 * C02CA02 Indoramin
 * C02CA03 Trimazosin
 * C02CA04 Doxazosin
 * C02CA06 Urapidil

C02CC Guanidine derivatives

 * C02CC01 Betanidine
 * C02CC02 Guanethidine
 * C02CC03 Guanoxan
 * C02CC04 Debrisoquine
 * C02CC05 Guanoclor
 * C02CC06 Guanazodine
 * C02CC07 Guanoxabenz

C02DA Thiazide derivatives

 * C02DA01 Diazoxide

C02DB Hydrazinophthalazine derivatives

 * C02DB01 Dihydralazine
 * C02DB02 Hydralazine
 * C02DB03 Endralazine
 * C02DB04 Cadralazine

C02DC Pyrimidine derivatives

 * C02DC01 Minoxidil

C02DD Nitroferricyanide derivatives

 * C02DD01 Nitroprusside

C02DG Guanidine derivatives

 * C02DG01 Pinacidil

C02KA Alkaloids, excluding rauwolfia

 * C02KA01 Veratrum

C02KB Tyrosine hydroxylase inhibitors

 * C02KB01 Metirosine

C02KC MAO inhibitors

 * C02KC01 Pargyline

C02KD Serotonin antagonists

 * C02KD01 Ketanserin

C02KX Other antihypertensives

 * C02KX01 Bosentan
 * C02KX02 Ambrisentan
 * C02KX03 Sitaxentan
 * C02KX04 Macitentan

C02LA Rauwolfia alkaloids and diuretics in combination

 * C02LA01 Reserpine and diuretics
 * C02LA02 Rescinnamine and diuretics
 * C02LA03 Deserpidine and diuretics
 * C02LA04 Methoserpidine and diuretics
 * C02LA07 Bietaserpine and diuretics
 * C02LA08 Rauwolfia alkaloids, whole root and diuretics
 * C02LA09 Syrosingopine and diuretics
 * C02LA50 Combinations of rauwolfia alkaloids and diuretics including other combinations
 * C02LA51 Reserpine and diuretics, combinations with other drugs
 * C02LA52 Rescinnamine and diuretics, combinations with other drugs
 * C02LA71 Reserpine and diuretics, combinations with psycholeptics

C02LB Methyldopa and diuretics in combination

 * C02LB01 Methyldopa (levorotatory) and diuretics

C02LC Imidazoline receptor agonists in combination with diuretics

 * C02LC01 Clonidine and diuretics
 * C02LC05 Moxonidine and diuretics
 * C02LC51 Clonidine and diuretics, combinations with other drugs

C02LE Alpha-adrenoreceptor antagonists and diuretics

 * C02LE01 Prazosin and diuretics

C02LF Guanidine derivatives and diuretics

 * C02LF01 Guanethidine and diuretics

C02LG Hydrazinophthalazine derivatives and diuretics

 * C02LG01 Dihydralazine and diuretics
 * C02LG02 Hydralazine and diuretics
 * C02LG03 Picodralazine and diuretics
 * C02LG51 Dihydralazine and diuretics, combinations with other drugs
 * C02LG73 Picodralazine and diuretics, combinations with psycholeptics

C02LK Alkaloids, excluding rauwolfia, in combination with diuretics

 * C02LK01 Veratrum and diuretics

C02LL MAO inhibitors and diuretics

 * C02LL01 Pargyline and diuretics

C02LX Other antihypertensives and diuretics

 * C02LX01 Pinacidil and diuretics

C02N Combinations of antihypertensives in ATC-group C02

 * Empty group